Pulmonary alveolar microlithiasis
Pulmonary Alveolar Microlithiasis (PAM) is a rare, autosomal recessive lung disease characterized by the accumulation of small stone-like calcium phosphate microliths within the alveoli.
Pronunciation
Pulmonary: /pʊlˈmɛnəri/ Alveolar: /ælˈviːələr/ Microlithiasis: /ˌmaɪkroʊlɪˈθaɪəsɪs/
Etymology
The term "Pulmonary Alveolar Microlithiasis" is derived from the following roots:
- Pulmonary: From Latin pulmonarius, from pulmo meaning "lung".
- Alveolar: From Latin alveolus meaning "small cavity", referring to the small air sacs in the lungs.
- Microlithiasis: From Greek micros meaning "small", lithos meaning "stone", and -iasis meaning "condition".
Symptoms
The symptoms of Pulmonary Alveolar Microlithiasis can vary, but often include shortness of breath, cough, and fatigue. Many individuals with this condition may remain asymptomatic for a long period.
Diagnosis
Diagnosis of Pulmonary Alveolar Microlithiasis is typically made through a combination of chest X-ray, CT scan, and lung biopsy. Genetic testing can also be used to identify mutations in the SLC34A2 gene, which is associated with this condition.
Treatment
There is currently no cure for Pulmonary Alveolar Microlithiasis. Treatment is focused on managing symptoms and improving quality of life. This may include oxygen therapy, pulmonary rehabilitation, and in severe cases, lung transplantation.
See also
References
External links
- Medical encyclopedia article on Pulmonary alveolar microlithiasis
- Wikipedia's article - Pulmonary alveolar microlithiasis
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski